Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Dr. Reddy’s Laboratories Ltd ADR (REDYy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Dr. Reddy’s Labs ADR historical data, for real-time data please try another search
59.00 +0.50    +0.85%
05/10 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US2561352038 
S/N:  659157
  • Volume: 0
  • Bid/Ask: 59.00 / 59.50
  • Day's Range: 59.00 - 59.00
Dr. Reddy’s Labs ADR 59.00 +0.50 +0.85%

REDYy Income Statement

 
Featured here, the Income Statement (earnings report) for Dr. Reddy’s Laboratories Ltd ADR, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Income Statement
Period Ending: 2015
31/03
2014
31/12
2014
30/09
2014
30/06
Total Revenue 38704 38431 35879 35175
Revenue 38704 38431 35879 35175
Other Revenue, Total - - - -
Cost of Revenue, Total 17483 16079 14893 14331
Gross Profit 21221 22352 20986 20844
Total Operating Expenses 32584 31205 29414 28700
Selling/General/Admin. Expenses, Total 10082 11151 10673 10679
Research & Development 5144 4316 4113 3875
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) - -138 -145 -110
Other Operating Expenses, Total -125 -203 -120 -75
Operating Income 6120 7226 6465 6475
Interest Income (Expense), Net Non-Operating -189 1060 472 534
Gain (Loss) on Sale of Assets - - - -
Other, Net - - - -
Net Income Before Taxes 5931 8286 6937 7009
Provision for Income Taxes 742 2541 1196 1505
Net Income After Taxes 5189 5745 5741 5504
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 5189 5745 5741 5504
Total Extraordinary Items - - - -
Net Income 5189 5745 5741 5504
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 5189 5745 5741 5504
Dilution Adjustment - - - -
Diluted Net Income 5189 5745 5741 5504
Diluted Weighted Average Shares 170.97 170.93 170.86 170.72
Diluted EPS Excluding Extraordinary Items 30.35 33.61 33.6 32.24
DPS - Common Stock Primary Issue - 18.38 - -
Diluted Normalized EPS 30.35 33.05 32.9 31.73
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RDY Comments

Write your thoughts about Dr.Reddy’s Laboratories Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email